Akari Therapeutics (DE:CLA1)
FRANKFURT:CLA1
Earnings Data
Report Date
May 20, 2027TBA (Confirmed)
Period Ending
2027 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-8.22Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
DE:CLA1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:CLA1 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2026 | €0.06 | €0.06 | 0.00% |
Apr 07, 2026 | €0.06 | €0.06 | +10.91% |
Sep 25, 2025 | €22.60 | €35.20 | +55.75% |
May 15, 2025 | €46.80 | €44.40 | -5.13% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Akari Therapeutics (DE:CLA1) report earnings?
Akari Therapeutics (DE:CLA1) is schdueled to report earning on May 20, 2027, TBA (Confirmed).
What is Akari Therapeutics (DE:CLA1) earnings time?
Akari Therapeutics (DE:CLA1) earnings time is at May 20, 2027, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Akari Therapeutics stock?
The P/E ratio of Akari Therapeutics is N/A.
What is DE:CLA1 EPS forecast?
Currently, no data Available